Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
The ALAD enzyme is composed of 8 identical subunits and catalyzes the condensation of 2 molecules of delta-aminolevulinate to form porphobilinogen (a precursor of heme, cytochromes and other hemoproteins). Zusätzlich bieten wir Ihnen Aminolevulinate Dehydratase Kits (41) und Aminolevulinate Dehydratase Proteine (11) und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 69 products:
Human Polyclonal ALAD Primary Antibody für WB - ABIN513229
Anand, Wilson, Hasan, Maytin: Vitamin D3 enhances the apoptotic response of epithelial tumors to aminolevulinate-based photodynamic therapy. in Cancer research 2011
Cow (Bovine) Polyclonal ALAD Primary Antibody für WB - ABIN2776921
Tang, Breinig, Stith, Mischel, Tannir, Kokona, Fairman, Jaffe: Single amino acid mutations alter the distribution of human porphobilinogen synthase quaternary structure isoforms (morpheeins). in The Journal of biological chemistry 2006
Human Polyclonal ALAD Primary Antibody für IHC, IHC (p) - ABIN4279102
Moreno-Navarrete, Rodríguez, Ortega, Becerril, Girones, Sabater-Masdeu, Latorre, Ricart, Frühbeck, Fernández-Real: Heme Biosynthetic Pathway is Functionally Linked to Adipogenesis via Mitochondrial Respiratory Activity. in Obesity (Silver Spring, Md.) 2018
ALAD genetic polymorphisms contribute to high blood lead levels in occupational exposed workers and may predict risk of lead poisoning.
The delta-aminolevulinate dehydratase activity was significantly lower in pregnant women with gestational diabetes mellitus.
The ALAD gene influences bone density among lead workers.
The frequencies of genotype and allelic variants of ALAD rs1800435 did not differ significantly between patients with essential tremor (ET) and controls, and were not influenced by gender. Subjects carrying the ALAD rs1800435CC genotype (wild-type) and the HMOX2 (zeige HMOX2 Antikörper) rs1051308GG genotype or the HMOX2 (zeige HMOX2 Antikörper) rs1051308G allele had significantly decreased risk for ET.
ALAD SNP rs818708 is significantly associated with risk of lead poisoning.
Overexpression of delta-aminolevulinate dehydratase (ALAD)suppresses breast cancer cell proliferation and invasion and inhibits the epithelial-mesenchymal transition phenotype.
Delta-aminolevulinate dehydratase activity and oxidative stress markers were significantly lowered in preeclampsia.
Results show statistically significant association between the maternal ALAD G177C polymorphism and placental lead levels.
Maternal ALAD gene polymorphism can affect early neonatal neurobehavioral development by influencing the blood lead level.
Genetic variation of ALAD is associated with blood lead level.
this study demonstrated for the first time the involvement of striatal delta-ALA-D activity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and its correlation with the MPO (zeige MPO Antikörper) activity.
Similar to its role at the beta-globin (zeige HBB Antikörper) promoter, KLF1 (zeige KLF1 Antikörper) induces factor recruitment and chromatin changes at the Alad1b promoter in a temporally-specific manner
The data supports the hypothesis that ALAD, an important enzyme for heme synthesis, is also important as a proteasome interacting protein.
The ALAD enzyme is composed of 8 identical subunits and catalyzes the condensation of 2 molecules of delta-aminolevulinate to form porphobilinogen (a precursor of heme, cytochromes and other hemoproteins). ALAD catalyzes the second step in the porphyrin and heme biosynthetic pathway\; zinc is essential for enzymatic activity. ALAD enzymatic activity is inhibited by lead and a defect in the ALAD structural gene can cause increased sensitivity to lead poisoning and acute hepatic porphyria.
, aminolevulinate, delta-, dehydratase
, delta-aminolevulinic acid dehydratase
, Delta-aminolevulinic acid dehydratase
, aminolevulinate dehydratase
, delta-aminolevulinic acid dehydratase-like
, delta - aminolevulinic acid dehydratase